Related Experiment Video
Updated: Sep 4, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint
Laura Mannarino1,2, Federica Mirimao3, Nicolò Panini3
1Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy.
Abstract:
Although clinical antitumor activity of Tumor Treating Fields (TTFields) has been reported in malignant pleural mesothelioma (MPM) patients, the mechanisms behind the different selectivity displayed by the various MPM histotypes to this physical therapy has not been elucidated yet. Taking advantage of the development of well characterized human MPM cell lines derived from pleural effusion and/or lavages of patients' thoracic cavity, we investigated the biological effects of TTFields against these cells, representative of epithelioid, biphasic, and sarcomatoid histotypes. Growth inhibition and cell cycle perturbations caused by TTFields were investigated side by side with RNA-Seq analyses at different exposure times to identify pathways involved in cell response to treatment. We observed significant differences of response to TTFields among the cell lines. Cell cycle analysis revealed that the most sensitive cells (epithelioid CD473) were blocked in G2M phase followed by formation of polyploid cells. The least sensitive cells (sarcomatoid CD60) were only slightly affected by TTFields with a general delay in all cell cycle phases. Apoptosis was present in all samples, but while epithelioid cell death was already observed during the first 24 h of treatment, sarcomatoid cells needed longer times before they engaged apoptotic pathways. RNA-Seq experiments demonstrated that TTFields induced a transcriptional response already detectable at early time points (8 h). The number of differentially expressed genes was higher in CD473 than in CD60 cells, involving several pathways, such as those pertinent to cell cycle checkpoints, DNA repair, and histone modifications. Our data provide further support to the notion that the antitumor effects of TTFields are not simply related to a non-specific reaction to a physical stimulus, but are dependent on the biological background of the cells and the particular sensitivity to TTFields observed in epithelioid MPM cells is associated with a higher transcriptional activity than that observed in sarcomatoid models.
Insights
Tumor Treating Fields (TTFields) show varied efficacy in malignant pleural mesothelioma (MPM) histotypes. Epithelioid MPM cells are more sensitive to TTFields, exhibiting cell cycle arrest and higher transcriptional activity than sarcomatoid cells.
Area of Science:
- Oncology
- Biophysics
- Cell Biology
Background:
- Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer.
- Tumor Treating Fields (TTFields) are a physical therapy showing clinical antitumor activity in MPM.
- The differential response of MPM histotypes to TTFields remains mechanistically unclear.
Purpose of the Study:
- To investigate the biological effects of TTFields on well-characterized human MPM cell lines representing epithelioid, biphasic, and sarcomatoid histotypes.
- To elucidate the molecular mechanisms underlying the differential sensitivity of MPM histotypes to TTFields.
Main Methods:
- Utilized human MPM cell lines derived from patient samples.
- Assessed TTFields' effects on cell growth, cell cycle progression, and apoptosis.
- Performed RNA-sequencing (RNA-Seq) at various time points to analyze transcriptional changes.
Main Results:
- Observed significant differences in TTFields response among MPM histotypes.
- Epithelioid cells (CD473) showed high sensitivity, with G2M cell cycle arrest and polyploidy.
- Sarcomatoid cells (CD60) exhibited lower sensitivity, with delayed cell cycle progression and slower induction of apoptosis.
- RNA-Seq revealed TTFields induced early transcriptional responses, with greater gene expression changes in sensitive epithelioid cells involving cell cycle, DNA repair, and histone modification pathways.
Conclusions:
- TTFields' antitumor effects are dependent on the specific biological characteristics of MPM cells.
- Epithelioid MPM cells demonstrate higher sensitivity to TTFields, associated with robust transcriptional responses.
- Sarcomatoid MPM cells are less sensitive, showing a muted transcriptional response to TTFields.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
The Tumor Microenvironment
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...

